Cracking “Undruggable” Cancer Proteins: Precision Oncology Meets p53
The development of KRAS inhibitors has ushered in a new era in precision oncology and renewed efforts in therapeutic...
Tag: p53
The development of KRAS inhibitors has ushered in a new era in precision oncology and renewed efforts in therapeutic...
Hugh Gannon, PhD, a recipient of the 2013 Anna D. Barker Fellowship in Basic Cancer Research, is studying p53's...